Parsatuzumab Explained

Parsatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7.[1]

This drug was developed by Genentech/Roche.[2]

References

  1. . International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107 . WHO Drug Information . 26 . 2 . 2012 .
  2. http://www.ama-assn.org/resources/doc/usan/parsatuzumab.pdf Statement On A Nonproprietary Name Adopted By The USAN Council - Parsatuzumab

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Parsatuzumab".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.